PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29449335-1	2018	OBJECTIVE: Bempedoic acid (BemA; ETC-1002) is a novel drug that targets hepatic ATP-citrate lyase to reduce cholesterol biosynthesis.	8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid	11-25	ATP citrate lyase	Sus scrofa	80-97	
29449335-1	2018	OBJECTIVE: Bempedoic acid (BemA; ETC-1002) is a novel drug that targets hepatic ATP-citrate lyase to reduce cholesterol biosynthesis.	8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid	27-31	ATP citrate lyase	Sus scrofa	80-97